Clinical Trial Update: Administration of BIIB028 to Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 trial of BIIB028 in adults with advanced solid tumors, summarizing safety, tolerability, and dosing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BIIB028

Snippet

Sponsor: Biogen | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED